Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer
NCT00754858
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
belotecan hydrochloride
DRUG:
cisplatin
Sponsor
Yonsei University